Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme

Vincent Caval (1) , Mohamed Bouzidi (1) , Rodolphe Suspène (1) , Hélène Laude (1) , Marie-Charlotte Dumargne (2) , Anu Bashamboo (2) , Thomas Krey (3) , Jean Pierre Vartanian (1) , Simon Wain-Hobson (1)

1 Rétrovirologie Moléculaire
2 Génétique du Développement humain - Human developmental genetics
3 Virologie Structurale

The human APOBEC3A and APOBEC3B genes (A3A and A3B) encode DNA mutator enzymes that deaminate cytidine and 5-methylcytidine residues in single-stranded DNA (ssDNA). They are important sources of mutations in many cancer genomes which show a preponderance of CG->TA transitions. Although both enzymes can hypermutate chromosomal DNA in an experimental setting, only A3A can induce double strand DNA breaks, even though the catalytic domains of A3B and A3A differ by only 9% at the protein level. Accordingly we sought the molecular basis underlying A3B attenuation through the generation of A3A-A3B chimeras and mutants. It transpires that the N-terminal domain facilitates A3B activity while a handful of substitutions in the catalytic C-terminal domain impacting ssDNA binding serve to attenuate A3B compared to A3A. Interestingly, functional attenuation is also observed for the rhesus monkey rhA3B enzyme compared to rhA3A indicating that this genotoxic dichotomy has been selected for and maintained for some 38 million years. Expression of all human ssDNA cytidine deaminase genes is absent in mature sperm indicating they contribute to somatic mutation and cancer but not human diversity.

Domaines: Sciences du Vivant [q-bio]

Vincent Caval, Mohamed Bouzidi, Rodolphe Suspène, Hélène Laude, Marie-Charlotte Dumargne, et al.. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme. Nucleic Acids Research, 2015, 43 (19), pp.9340-9349. ⟨10.1093/nar/gkv935⟩. ⟨pasteur-03520063⟩